This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Morningside Venture Investments Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Guy DiPIERRO: Bio-Synchronous Drug Delivery Innovation
Introduction
Guy DiPIERRO is an inventor based in San Francisco, California. His patent work focuses on adapting bioactive-agent delivery to a patient’s individual biological and temporal characteristics.
Latest Patents
DiPIERRO is associated with one patent, titled “Optimized Bio-Synchronous Bioactive Agent Delivery System.” The invention describes a treatment protocol that accounts for a patient’s biological and temporal characteristics and uses a delivery device to administer a bioactive agent. It also involves continually collecting and analyzing patient data, including physical, psychological, temporal, and environmental information, to assess whether the treatment protocol should be adjusted. When changes are indicated, the system can modify the protocol and delivery-device use, and may provide reactive or proactive psychological support in different formats. The supplied information does not establish when this patent was granted or whether it is his most recent patent. His reported total is 1 patent.
Career Highlights
DiPIERRO’s described invention brings together personalized treatment planning, ongoing patient-data analysis, and adaptable drug delivery. The supplied information lists Morningside Venture Investments Limited as the company with which he works.
Collaborations
Alan Joel Levy is identified as DiPIERRO’s coworker. The available information does not specify their roles or describe particular joint patent work.
Conclusion
Guy DiPIERRO’s patent centers on a responsive, personalized approach to bio-synchronous drug delivery, combining patient-specific treatment protocols with ongoing monitoring and potential adjustments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile